An interventional study of Intensive rehabilitation program with CPNB in CRPS (Complex Regional Pain Syndrome) Type I, sponsored by Pôle Saint Hélier. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by Pôle Saint Hélier · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Complex Regional Pain Syndromes with a site in France — 6 open to participants now, 6 under way, none of them phase 3. Complex Regional Pain Syndromes · France.
Among the 17 studies in Complex Regional Pain Syndromes with a site in France, this one is the 10th largest by enrollment of the 13 interventional ones that give a count, is one of 5 that started in 2021, is one of 10 with no phase, and was the 9th registered.
206 studies on the registry are indexed under Complex Regional Pain Syndromes; 54 are open to participants now.
Browse Complex Regional Pain Syndromes studies →6 of the 17 studies in Complex Regional Pain Syndromes with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France
Ages 18+
Polyclinique de l'Europe · Sites in France
Ages 18+
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est · Sites in France
Ages 18+ · Healthy volunteers
Hospices Civils de Lyon · Sites in France
Ages 12–20
Elsan · Sites in France
Ages 18–75
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 41 Complex Regional Pain Syndromes studies recruiting now, 19 (46%) set no upper age limit and 16 (39%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 3
First in 2012; this study’s year is marked. 5 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 30 is below the median of 40 across 152 interventional studies indexed under Complex Regional Pain Syndromes.
Median enrollment 60 across the 13 interventional studies, 33 across the 4 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 17 have an industry lead sponsor. The 10 most frequent:
Pôle Saint Hélier is the lead sponsor of 23 studies on the registry; 4 are open to participants now.
Pôle Saint Hélier has 1 study filed under Complex Regional Pain Syndromes — fewer than ten, so there is no comparison to draw.
2 of the studies in Complex Regional Pain Syndromes with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07361692Polyclinique de l'EuropeEffectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome | 2027-06-01 |
| NCT07349173Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord EstPeripersonal Space Representation in Upper Limb Segmental Exclusion | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Complex Regional Pain Syndromes with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study evaluates the relationship between the duration of evolution of SDRC1 and the efficacy of continuous peripheral nerve block (c-PNB) associated with an intensive rehabilitation program to improve the therapeutic strategy of SDRC1.
The main hypothesis of this study is that if c-PNB is proposed earlier, the recovery, measured with a scale achievement of objectives, will be better.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Intensive rehabilitation program with CPNB
The patient will have an intensive rehabilitation program (two 30-minute kinesitherapy sessions every day and 30-minute occupational therapy sessions 5 days a week) with the CPNB. The patient will have follow-up consultation at 1 month, 3 month, 6 month and 1 year after the beggining of the intensive rehabilitation program
The composite score (the summation of the 3 Goal Attainment Scaling (GAS) scores)
The improvement of the composite score following BNPc combined with intensive rehabilitation.
Time frame: 1 year
Pain assessment
EVA (Visual Analogue Scale, VAS) for all the patients at each visit This is a measure of pain intensity on a scale of 0 (no pain) to 10 (very severe pain). We will assess the percentage of pain relief with the EVA scale, before and after the PCNB.
Time frame: 1 year
Anxiety assessment
Hospital Anxiety and Depression (HAD) scale for all the patients at each visit There will be 2 scores One to assess anxiety : from 0 to 21 and one to assess depression : from 0 to 21 Higher scores mean a worse outcome.
Time frame: 1 year
Arthrometry assessment
For an upper limb block : Passive and active arthrometry (angular measurements for shoulder, elbow and wrist) For a block of the lower limb : Passive and active arthrometry (angular measurements for hip, knee and ankle)
Time frame: 1 year
hand joint assessment
For an upper limb block : Kapandji Index at each visit (between 0 to 10)
Time frame: 1 year
gripping force assessment
For an upper limb block, gripping force will be evaluated with a Jamar and Pinch dynamometer at each visit after BNPc
Time frame: 1 year
activity assessment
For an upper limb block, the activity limitation will be evaluated by leroux's scapular index (LSI) with a global score out of 100 at each visit after BNPc
Time frame: 1 year
manual dexterity test
For an upper limb block, the dexterity will be evaluated by a Box and Block Test at each visit after BNPc
Time frame: 1 year
Assessment of activity limitation for a block of the upper limb
DASH scale at each visit
Time frame: 1 year
Assessment of activity limitation for a block of the lower limb
WOMAC score at each visit
Time frame: 1 year
Assessment of functional capacity
TDM6 at each visit (number of metres travelled by the patient during 6 minutes)
Time frame: 1 year
Assessment of the restriction of participation in social life
Return to work
Time frame: 1 year
Evaluation of the effective dose
\- Recording of effective doses (continuous and bolus)
Time frame: During the CPNB
Evaluation of the tolerance of CPNB
\- Incident reporting
Time frame: During the CPNB
Ran from Feb 2021 to primary completion in Mar 2026, 60 months.
Of 66 non-industry interventional studies with no phase under Complex Regional Pain Syndromes, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 60. This study's 60 months is above that.
Counting every sponsor, half of 67 studies reached it within 24 months; a quarter within 14 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Complex Regional Pain Syndromes →
Pôle Saint Hélier